🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Couldn’t have asked for better companions on this journey

My journey as an Uro-oncology Pelvic Fellow in Oxford University Hospitals has come to an end. Bitter-sweet feelings as I travel back home, but grateful for all the people I’ve met, lessons learned and both personal and professional growth. Ready for the next stage!

Demà!!! No et perdis la sessió gratuïta organitzada per l'Oficina del Pacient de la Societat Catalana d'Urologia i suma't a #Movember ! SCU

.Nikita Bhatt discusses how social media interventions can be utilized in urology. #urology #urologist #UroSoMe Watch now: urologytimes.com/view/dr-bhatt-…

Absolutely grateful to work in this outstanding #urology department. Always embracing #Innovation and following the tradition of recognised Prof. Gilvernet school. Never stop learning and giving the best for our patients. And with a very special spirit: Hospital Clínic brand.

Interesting experience at #PROSCA23. Engaging discussions, thought-provoking sessions led by multidisciplinary experts and a shared commitment to improve patient outcomes and quality of life. #ProstateCancer

Grateful for the professional and personal growth during my time at the Pelvic Uro-Oncology Fellowship 🚀 Check out the opportunity to join this program surrounded by an incredible team #Oxford_Urology

🎥Antoni Vilaseca, MD, of Hospital Clínic discusses the potential of TAR-210, a bladder-inserted drug delivery system, for NMIBC. Promising safety profile suggests reduced need for surgery: 📷ow.ly/ZY5B50QgWTy📷 #ESMO23 #UroOnc #UroSoMe #BlcSM

One day your are swimming in the deep blue sea, the other day in the deep molecular science 🧬 🐋 #urology #research #uroscience

A new era is coming for the treatment of NMIBC. Don’t miss this updated summary European Urology Oncology authors.elsevier.com/c/1jDEc9Cfv--d…

Our #StatisticalAnalysisPlan now published in BMC #Trials #NotLongNow!! SITU Oxford OCTRU Trials Hub Nuffield Department of Surgical Sciences trialsjournal.biomedcentral.com/articles/10.11…

What an amazing 3 days in Budapest at the #UROonco24, plenty of interesting discussions about the hot topics in uro-oncology and also blessed to have taken part in the STEPS program to discuss about #bladdercancer and #UTUC with experts like Jeremy Teoh and Evanguelos Xylinas

The IDENTIFY BURST Urology risk calculator predicts urinary tract cancer using patient characteristics. ⭕️It stratifies haematuria patients into very-low-risk, low-risk, intermediate-risk, and high-risk groups. 📈External validation involved 3582 patients, achieving an AUC of

Really like this little paper we've published in the brilliant new BJUI Compass on 10 yrs of #ASAP at #Oxford_Urology. THM - not all subsequent biopsies after ASAP are #LowGrade. In fact 24.1% had GG≥2 within 2yrs of diagnosis of ASAP. Thines Krishna doi.org/10.1002/bco2.4…

🗣️🗣️Ahora sí 📢Muy feliz de anunciar nuestro Curso de Cáncer de Vejiga dirigido a médicos jóvenes. Ponentes expertos 🤩 + 1 noche y cena 🥂 en hotel espectacular 🌊 + ambiente distendido 🥳 + casos prácticos 🏥 SCU Joan Palou Redorta Fernando Lozano 📌 scurologia.cat/agenda/activit…

In patients with muscle-invasive bladder cancer, extended lymphadenectomy did not improve disease-free or overall survival as compared with the standard procedure and was associated with higher morbidity and mortality. Full SWOG S1011 trial results: nej.md/4dBI8UN

Delighted to share our latest on #18F_PSMA_PET just published in cool new JU Open Plus! •n=1335 scans from 1220 men •1°: PSMA 96% vs MRI 89% sens. for pros lesions at RP •2°: PSA 0.2-0.49 post RP/RT ➡️ avidity in 57.8% BUT high false +ves (esp ribs) journals.lww.com/juop/fulltext/…

A summary of some of the position statements is attached below: Jeremy Teoh Gianluca Giannarini Maria J. Ribal Clàudia Mercader Esther Garcia Rojo Benjamin Pradere Vito Cucchiara @marcvangurp Carla Bezuidenhout Jarka Bloemberg James N'Dow DrG

Trial CI Bryant_Lab delighted to read out #TRANSLATE_Trial results during #GameChanger session European Association of Urology (EAU) #EAU25 Thank you to all our investigators, recruiting sites, funders National Institute for Health and Care Research and, most importantly, our 1126 pts! thelancet.com/journals/lanon… Trial visual abstract below ⬇️

Great dissemination committee meeting yesterday, lots of new ideas discussed on how best to disseminate the good work of the #eauguidelines European Association of Urology (EAU). Some exciting new features coming along, watch this space! #EAU25